FDA — authorised 23 December 1999
- Marketing authorisation holder: INO
- Status: approved
🇺🇸 Inomax in United States
FDA authorised Inomax on 23 December 1999
Marketing authorisations
FDA — authorised 23 December 1999
- Application: NDA020845
- Marketing authorisation holder: MALLINCKRODT IRELAND
- Local brand name: INOMAX
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 2 October 2018
- Application: ANDA207141
- Marketing authorisation holder: VERO BIOTECH INC
- Local brand name: NOXIVENT
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 20 December 2019
- Application: NDA202860
- Marketing authorisation holder: VERO BIOTECH INC
- Local brand name: GENOSYL
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 27 July 2023
- Application: ANDA203144
- Marketing authorisation holder: AIRGAS THERAP
- Status: approved
Inomax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Inomax approved in United States?
Yes. FDA authorised it on 23 December 1999; FDA authorised it on 23 December 1999; FDA authorised it on 2 October 2018.
Who is the marketing authorisation holder for Inomax in United States?
INO holds the US marketing authorisation.